Atlas Trials

Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia

Clinical trial NCT02313233 · COMPLETED

Trial details

NCT number
NCT02313233
Sponsor
Golden Biotechnology Corporation
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Benign Prostatic Hyperplasia
Start date
2013-12-01
Primary completion
2015-05-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.